EGFR and neoplasm: Metzger et al. showed that KDM4A upregulation demethylated EGFR by downregulating H3K9me3 at the EGFR promoter, which increased the proliferation, sphere-forming capacity in vitro, and xenograft tumor growth of triple-negative breast CSCs in vivo [147].